Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics

Acorda Therapeutics, Inc. (ACOR)

Today's Latest Price: $1.76 USD

0.08 (-4.35%)

Updated Dec 13 12:00am

Add ACOR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

ACOR Stock Summary

  • With a price/sales ratio of 0.31, Acorda Therapeutics Inc has a higher such ratio than only 10.9% of stocks in our set.
  • Revenue growth over the past 12 months for Acorda Therapeutics Inc comes in at -48.01%, a number that bests merely 3.71% of the US stocks we're tracking.
  • The volatility of Acorda Therapeutics Inc's share price is greater than that of 97.77% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to ACOR, based on their financial statements, market capitalization, and price volatility, are QUMU, XONE, ICAD, DOMO, and MRIN.
  • ACOR's SEC filings can be seen here. And to visit Acorda Therapeutics Inc's official web site, go to
ACOR Daily Price Range
ACOR 52-Week Price Range

ACOR Stock Price Chart More Charts

ACOR Price/Volume Stats

Current price $1.76 52-week high $17.57
Prev. close $1.84 52-week low $1.49
Day low $1.74 Volume 1,161,100
Day high $1.92 Avg. volume 1,249,714
50-day MA $2.09 Dividend yield N/A
200-day MA $6.62 Market Cap 84.53M

Acorda Therapeutics, Inc. (ACOR) Company Bio

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The company was founded in 1995 and is based in Ardsley, New York.

ACOR Latest News Stream

Event/Time News Detail
Loading, please wait...

ACOR Latest Social Stream

Loading social stream, please wait...

View Full ACOR Social Stream

ACOR Price Returns

1-mo -3.83%
3-mo -54.40%
6-mo -77.08%
1-year -89.12%
3-year -91.50%
5-year -95.42%
YTD -88.70%
2018 -27.37%
2017 14.10%
2016 -56.05%
2015 4.67%
2014 39.97%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5291 seconds.